Certara appoints dr. chris bouton as chief technology officer to advance ai in-silico drug discovery and development platform

Radnor, pa., july 31, 2025 (globe newswire) -- certara, inc. (nasdaq: cert), a global leader in model-informed drug development, today announced the appointment of christopher bouton, ph.d.

CERT Ratings Summary

CERT Quant Ranking